DEVARTLab holds the 47th Scientific Conference Towards Better Health to raise awareness about risks and prevention of heart disease
DEVARTLab, the pioneer in functional food and innovative pharmaceuticals, organized its 47th conference "For A Better Quality of Life # 47", under title "Towards Better Health and Maximum Protection from Cardiovascular Diseases", in the presence of best group of professors and medical associations’ heads in Egypt, at Hurghada
The activities of the scientific meeting began with DEVARTLab vision review, and the vision impressed all audience including our eminent chairpersons, and meeting continued with cardiology history in Egypt review
At the beginning of scientific meeting sessions, Prof. Dr. Islam Shawky, Professor of Cardiology at Al-Azhar University and President of the Egyptian Heart Association, spoke about the increase in the rates of arterial calcification in the last decade and the extent of danger of calcium deposition on blood vessels’ wall and heart tissue in the deterioration of the health of patients with heart disease, atherosclerosis, diabetes and kidney disease
He also addressed the role of "Vitamin K2" in patient protection, preventing the deposition of calcium on blood vessels’ wall and heart tissues, reducing mortality rates resulting from arterial calcification, and its role in reducing the complications of atherosclerosis.
Prof. Dr. Atef Al-Bahri also emphasized the increase in atherosclerosis patients’ rate recently, and how lifestyle is a major factor in increasing these rates, and the importance of finding a solution for this problem
He also indicated how to treat it from the beginning of diagnosis and the introduction of Advochol 10 mg of (rosuvastatin) by DEVARTLab, and its effectiveness in controlling the levels of low-density lipids and triglycerides in blood.
Also, he spoke about the importance of Mena Q to ensure that calcium is not deposited on blood vessels’ wall and reduce atherosclerosis complications and the deterioration of the disease
Dr. Hemmat Al-Haddad, Professor of Internal Medicine, Diabetes and Endocrinology at Kasr Al-Ainy and Head of the Intensive Care Unit at Kasr Al-Ainy pointed out that DEVARTLab offers new and innovative solutions in the Egyptian pharmaceutical market, including Mena Q, Pharafero 18 and 18 Plus which is one of the best products in iron deficiency anemia management due to its effectiveness without side effects such as abdominal pain, constipation and other problems that have exhausted the Egyptian patient who is looking for an optimum solution for iron deficiency anemia
More than 200 doctors, professors and consultants of cardiology, internal Medicine, diabetes and nephrology from 20 governorates all over Egypt have attended the conference